Not found

Shiladitya Sengupta, PhD

Assistant Research Professor of Radiation Oncology, Institute for Academic Medicine
Assistant Research Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Sengupta is an Assistant Research Member in the department of Radiation Oncology of Houston Methodist Research Institute, and is also affiliated to Houston Methodist Institute for Academic Medicine and Weill Cornell Medical College, New York as Assistant Research Professor. Before joining Houston Methodist in September 2013, he was a Research Scientist at University of Texas Medical Branch at Galveston. He was a 2011-2013 Keck Fellow of Gulf Coast Consortia's Computational Cancer Biology Training Program, funded by the Cancer Prevention and Research Institute of Texas. He received PhD in 2008 from Jadavpur University, India, and is also a recipient of 2007 Young Scientist Award from Indian Institute of Human Genetics. He also serves as a regular reviewer for DNA Repair, Mutation Research, Oncotarget, DNA and Cell Biology, etc.  

Description of Research

Dr. Sengupta supervises fresh graduate and undergraduate students in the Mitra laboratory.

Areas Of Expertise

Cell proliferation Drug resistance Transcription regulation Protein acetylation Genome damage response Genomic instability
Education & Training

PhD, Jadavpur University
MSc, University of Calcutta
Publications

Cancer Nanomedicine: Lessons for Immuno-Oncology
Sengupta, S 2017, Trends in Cancer, vol 3, no. 8, pp. 551-560. DOI: 10.1016/j.trecan.2017.06.006

Cancer Nanomedicine: Lessons for Immuno-Oncology
Sengupta, S 2017, Trends in Cancer, vol 3, no. 8, pp. 551-560. DOI: 10.1016/j.trecan.2017.06.006

Chromatin-Bound Oxidized a-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease
Vasquez, V, Mitra, J, Hegde, PM, Pandey, A, Sengupta, S, Mitra, S, Rao, SK & Hegde, ML 2017, Journal of Alzheimers Disease, vol 60, no. s1, pp. S133-S150. DOI: 10.3233/JAD-170342

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff
Bhattacharyya, A, Jain, N, Prasad, S, Jain, S, Yadav, V, Ghosh, S & Sengupta, S 2017, BMC Dermatology, vol 17, no. 1, 5. DOI: 10.1186/s12895-017-0058-5

Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Gupta, N, Kancharla, J, Kaushik, S, Ansari, A, Hossain, S, Goyal, R, Pandey, M, Sivaccumar, J, Hussain, S, Sarkar, A, Sengupta, A, Mandal, SK, Roy, M & Sengupta, S 2017, Chemical Science, vol 8, no. 3, pp. 2387-2395. DOI: 10.1039/c6sc05149a

Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Gupta, N, Kancharla, J, Kaushik, S, Ansari, A, Hossain, S, Goyal, R, Pandey, M, Sivaccumar, J, Hussain, S, Sarkar, A, Sengupta, A, Mandal, SK, Roy, M & Sengupta, S 2017, Chemical Science, vol 8, no. 3, pp. 2387-2395. DOI: 10.1039/c6sc05149a

Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Gupta, N, Kancharla, J, Kaushik, S, Ansari, A, Hossain, S, Goyal, R, Pandey, M, Sivaccumar, J, Hussain, S, Sarkar, A, Sengupta, A, Mandal, SK, Roy, M & Sengupta, S 2017, Chemical Science, vol 8, no. 3, pp. 2387-2395. DOI: 10.1039/c6sc05149a

Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Gupta, N, Kancharla, J, Kaushik, S, Ansari, A, Hossain, S, Goyal, R, Pandey, M, Sivaccumar, J, Hussain, S, Sarkar, A, Sengupta, A, Mandal, SK, Roy, M & Sengupta, S 2017, Chemical Science, vol 8, no. 3, pp. 2387-2395. DOI: 10.1039/c6sc05149a

Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Gupta, N, Kancharla, J, Kaushik, S, Ansari, A, Hossain, S, Goyal, R, Pandey, M, Sivaccumar, J, Hussain, S, Sarkar, A, Sengupta, A, Mandal, SK, Roy, M & Sengupta, S 2017, Chemical Science, vol 8, no. 3, pp. 2387-2395. DOI: 10.1039/c6sc05149a

Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Gupta, N, Kancharla, J, Kaushik, S, Ansari, A, Hossain, S, Goyal, R, Pandey, M, Sivaccumar, J, Hussain, S, Sarkar, A, Sengupta, A, Mandal, SK, Roy, M & Sengupta, S 2017, Chemical Science, vol 8, no. 3, pp. 2387-2395. DOI: 10.1039/c6sc05149a

Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Gupta, N, Kancharla, J, Kaushik, S, Ansari, A, Hossain, S, Goyal, R, Pandey, M, Sivaccumar, J, Hussain, S, Sarkar, A, Sengupta, A, Mandal, SK, Roy, M & Sengupta, S 2017, Chemical Science, vol 8, no. 3, pp. 2387-2395. DOI: 10.1039/c6sc05149a